CD45 (leukocyte common antigen) immunoreactivity in metastatic undifferentiated and neuroendocrine carcinoma: A potential diagnostic pitfall

Modern Pathology

Volumn 11, Issue 12, 1998, Pages 1204-1210

  Nandedkar, Meenakshi A ^a   Palazzo, Juan ^b   Abbondanzo, Susan L ^a   Lasota, Jerzy ^a   Miettinen, Markku ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Carcinoma; Immunohistochemistry; Leukocyte common antigen (LCA CD45); Lymphoma

Indexed keywords

CD45 ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; KERATIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; DESMOSOME; ELECTRON MICROSCOPY; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN GENE; IMMUNOREACTIVITY; LARGE CELL CARCINOMA; LUNG CARCINOMA; LYMPH NODE METASTASIS; MALE; METASTASIS; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; TONOFILAMENT; UNDIFFERENTIATED CARCINOMA;

ADULT; AGED; ANTIGENS, CD45; CARCINOMA, NEUROENDOCRINE; DESMOSOMES; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOENZYME TECHNIQUES; INTERMEDIATE FILAMENTS; KERATINS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; TUMOR MARKERS, BIOLOGICAL;

EID: 0032446748     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Warnke RA, Rouse RV. Limitations encountered in the application of tissue section immunodiagnosis to the study of lymphomas and related disorders. Hum Pathol 1985;16:326-31.
2. McDonnell JM, Beschorner WE, Kuhajda FP, DeMent SH. Common leukocyte antigen staining sarcoma. Lancer 1987; 59:1438-41.
3. Borowitz MJ, Stevanovic G, Gottfried M. Differential diagnosis of undifferentiated malignant tumors with monoclonal antibody T29/33. Hum Pathol 1984;15:928-34.
4. Kurtin PJ, Pinkus GS. Leukocyte common antigen: a diagnostic discriminant between hematopoietic neoplasms in paraffin sections using monoclonal antibodies. Correlation with immunologic studies and ultrastructural localization. Hum Pathol 1985;16:353-65.
5. Pizzolo G, Sloane J, Beverly P, Thomas JA, Bradstock KF, Mattingly S, et al. Differential diagnosis of malignant lymphoma and nonlymphoid tumors using monoclonal antileukocyte antibody. Cancer 1980;46:2640-7.
6. Weiss LM, Arber DA, Chang KL. CD45: a review. Appl Immunohistochem 1993;1:166-81.
7. Ramasamy I, Brisco M, Morley AA. Improved method for detecting monoclonal immunoglobulin heavy-chain rearrangement in B-cell neoplasms. J Clin Pathol 1992;45:770-5.
8. Wan JH, Trainor KJ, Brisco MJ, Morley AA. Monoclonality in B-cell lymphoma detected in paraffin wax-embedded sections using the polymerase chain reaction. J Clin Pathol 1990;43:888-90.
9. Battifora H, Trowbridge IS. A monoclonal antibody useful for the differential diagnosis between malignant lymphoma and nonhematopoietic neoplasms. Cancer 1983;51:816-21.
10. Petruch UR, Horny HP, Kaiserling EK. Frequent expression of hematopoietic and nonhematopoietic antigens by neoplastic plasma cells: an immunohistochemical study using formalin-fixed, paraffin-embedded tissue. Histopathology 1992;20:35-40.
11. Gustmann C, Altmannberger M, Osborne M, Griesser H, Feller AC. Cytokeratin expression and vimentin content in large-cell anaplastic lymphomas and other non-Hodgkin's lymphoma. Am J Pathol 1991;138:1413-22.
12. Donner LR, Pugh WC, Harms D. Keratin-positive, epithelial membrane antigen-positive solitary pelvic tumor with ultrastructural features of large cell lymphoma. Ultrastruct Pathol 1993;17:455-8.
13. Falini B, Pileri S, Stein H, Dieneman D, Dallenbach F, Delson G, et al. Variable expression of leukocyte common (CD45) phoma and nonlymphoid malignancies. Hum Pathol 1990; 21:624-9.
14. Tabibzadeh SS, Kong QF, Kapur S. Passive acquisition of leukocyte proteins is associated with changes in phosphorylation of cellular proteins and cell-cell adhesion properties. Am J Pathol 1994;145:930-40.
15. Lasota J, Hyjek E, Koo CH, Blonski J, Miettinen M. Cytokeratin-positive large-cell lymphomas of B-cell lineage: a study of five phenotypically unusual cases verified by polymerase chain reaction. Am J Surg Pathol 1996;20:346-54.
16. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors, and cultured cells. Cell 1982;31: 11-24.
17. Sun TT, Eichner R, Schermer A, Woodcock-Mitchell J. Classification, expression, and possible mechanisms of evolution of mammalian epithelial keratins: a unifying model. In: Levine AJ, van de Woude GF, Topp WC, Watson JD, editors. Cancer Cells I. The transformed phenotype. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1985. p. 169-83.
18. Wotherspoon AC, Norton AJ, Isaacson PG. Immunoreactive cytokeratins in plasmacytomas. Histopathology 1989;14:141-50.
19. Knapp AC, Franke WW. Spontaneous losses of control of cytokeratin gene expression in transformed, nonepithelial human cells occurring at different levels of regulation. Cell 1989;59:67-79.
20. Järvinen M, Andersson LC, Virtanen 1. K562 erythroleukcmia cells express cytokeratins 8, 18, and 19 and epithelial membrane antigen that disappear after induced differentiation. J Cell Physiol 1990;143:310-8.
21. Delsol G, Al Saati T, Gatter KC, Gerdes I, Schwarting R, Caveriviere P, et al. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large-cell lymphomas. Am J Pathol 1988;130:59-70.
22. Linder J. Immunohistochemistry in surgical pathology: the case of the undifferentiated malignant neoplasm. Clin Lab Med 1990;10:59-76.